IMMUNITYBIO ANNOUNCES FIRST PATIENTS IN EUROPE TREATED WITH ANKTIVA® PLUS BCG FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU

Reuters · 23h ago

Please log in to view news